QT Imaging Holdings, Inc.

QT Imaging Holdings, Inc.

NNASDAQ:QTI
1.80
USD
-0.08
(-4.26%)
-1.58EPS
56.04MMarket Cap
Apr 05Next Earn
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.04
- -
0.01
0.73
1.81
- -
Basic EPS, GAAP
-0.57
-0.29
-1.92
-1.35
-2.01
- -
Free Cash Flow per Basic Share
-0.29
-0.13
-0.84
-1.52
-0.87
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
Book Value per Share
0.14
1.34
-0.25
-0.36
0.54
- -
Tangible Book Value per Share
0.12
1.32
-0.25
-0.36
0.54
- -
Basic Weighted Avg Shares
10
10
3
7
10
15
Sales/Revenue/Turnover
- -
- -
- -
5
19
- -
Operating Margin (%)
-1,929.03
- -
-12,409.76
-249.58
-23.45
- -
Depreciation Expense
1
1
- -
- -
- -
- -
Net Income, GAAP
-5
-3
-6
-9
-21
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-1,482.99
- -
-15,113.25
-184.16
-111.4
- -
Working Capital
6
-4
-3
-5
14
- -
LT Debt
4
7
4
5
5
- -
Total Equity
3
29
-5
-10
6
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-17.63
- -
- -
- -
- -

Capital Structure

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
- -
- -
- -
LT Borrowings
5
15
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
12
14
15
Market Capitalization
71
56
37

Working Capital

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
21
29
- -
Cash, Cash Equivalents & STI
7
11
- -
Accounts Receivable, Net
6
7
- -
Inventories
7
10
- -
Total Current Liabilities
9
9
- -
Payables & Accruals
6
7
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-167.57%
Free Cash Flow
- -
- -
-10.26%
Net Income, GAAP
- -
- -
134.65%
Sales/Revenue/Turnover
- -
- -
287.89%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1
2
1
1
5
2025
3
4
4
8
19
2026
7
7
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.14
-0.06
-0.51
0.01
-1.35
2025
-1.21
-0.42
-0.47
-0.1
-2.01
2026
-0.25
-0.75
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Raluca Dinu
Full Time Employees
32
Sector
Finance
Industry
Financial conglomerates
Address
Three Hamilton Landing Novato CA United States 94949
IPO Date
Mar 5, 2024
Business
QT Imaging Holdings, Inc. is a medical technology company specializing in the research, development, and commercialization of innovative breast and body imaging systems using quantitative transmission (QT) ultrasound technology. The company’s flagship product is the FDA-cleared QTI Breast Acoustic CT™ Scanner, which produces high-resolution, true 3D images of the breast without radiation, compression, or contrast agents, providing a safer and more comfortable diagnostic solution. QT Imaging also integrates artificial intelligence and biomarkers into its platform to enhance early detection and diagnostic accuracy, targeting women with dense breast tissue or those underserved by conventional imaging methods. The company operates primarily in the United States with expanding global distribution channels. Founded in 2012 and headquartered in Novato, California, QT Imaging redefined breast cancer screening standards by developing technology that offers MRI-comparable resolution with a pain-free and efficient imaging experience. Recent strategic developments include an $18 million private placement financing round in 2025 to accelerate growth and an exclusive U.S. distribution agreement with NXC Imaging, Inc., a Canon Medical Systems subsidiary, aimed at broadening market reach and adoption. QT Imaging also expanded its international presence through a new strategic distribution partnership in Saudi Arabia. Leadership additions such as the appointment of industry veteran Satrajit Misra as Chief Commercial Officer and Jay Jennings as Chief Financial Officer reinforce its commercial and financial capabilities. Financially, the company eliminated all short-term liabilities and forecasts robust revenue growth, targeting $18 million in 2025 revenue with plans to increase to $39 million in 2026, driven by expanded scanner shipments and strategic partnerships. QT Imaging’s latest initiatives mark a transition from primarily a scanner company to a broader SaaS and biomarker-driven medical imaging franchise, emphasizing scalable, technology-enabled healthcare solutions for improved patient outcomes worldwide. The company continues to focus on accessibility, safety, and diagnostic precision to address critical clinical gaps and improve global health outcomes in breast cancer detection and beyond. QT Imaging is publicly traded on NASDAQ under the ticker QTI following its 2024 business combination with GigCapital5, marking its transition to a publicly listed entity. This description encapsulates QT Imaging Holdings, Inc.’s core product offerings, key recent corporate changes, and operational focus in the medical imaging industry.

Company News

  • QT Imaging Holdings, Inc. (QTI) Q3 2026 Earnings Call Transcript

  • QT Imaging Reports 75% Third Quarter Revenue Growth and Major Medicare Reimbursement Milestone

  • QT Imaging Secures First GCC Commercial Order from American Hospital Dubai, Plans Clinical Research Collaboration

  • QT Imaging Secures Medicare Outpatient Reimbursement for QTscan®, Effective January 2027

  • QT Imaging to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

  • QT Imaging to Report Third Quarter 2026 Financial Results and Host Conference Call on November 10, 2026

  • QT Imaging's Breast Acoustic CT™ Scanner Now Available Through National Group Purchasing Agreement with Premier

  • QT Imaging's Breast Acoustic CT™ Scanner Now Available Through National Group Purchasing Agreement with Premier

  • QT Imaging Announces CPT® Category III Code for 3D Breast Acoustic Imaging Now Effective

  • QT Imaging to Ring the Nasdaq Closing Bell on October 2 in Recognition of Breast Cancer Awareness Month

  • QT Imaging to be Honored at Premier's Annual Supplier Innovation Celebration

  • QT Imaging Appoints Imaging Industry Veteran Dr. Mark Winkler as Chief Medical Officer

  • QT Imaging Holdings, Inc. (QTI) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 Transcript

  • QT Imaging to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference

  • QT Imaging Issues Mid-Year 2026 CEO Letter to Shareholders

  • QT Imaging Holdings, Inc. (QTI) Q2 2026 Earnings Call Transcript

  • QT Imaging Delivers Strong Second Quarter Growth While Building the Foundation for Commercial Scale

  • QT Imaging to Report Second Quarter 2026 Financial Results and Host Conference Call on August 12, 2026

  • QT Imaging Advances Direct U.S. Commercial Strategy to Accelerate Adoption of its Breast Acoustic CT Scanner with Two Key Hires

  • QT Imaging Appoints Medical Imaging and Digital Health Executive Dr. Julia Albright as Chief Science Officer